Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Caribou Biosciences, Inc. (CRBU)  
$3.71 0.05 (1.33%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 88,430,000
Market Cap: 328.08(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.58 - $8.26
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Caribou Biosciences is a clinical-stage genome-editing biopharmaceutical company focused on developing transformative Clustered Regularly Interspaced Short Palindromic Repeats therapies for patients with devastating diseases. Co.'s primary product candidate, CB-010, is a clinical-stage allogeneic anti-CD19 chimeric antigen receptor (CAR)-T cell therapy with programmed cell death protein 1 removed from the CAR-T cell surface by a genome-edited knockout of the PDCDI gene. CB-012 is Co.'s allogeneic armored CAR-T cell product candidate targeting CD371, which is in preclinical development for the treatment of relapsed or refractory acute myeloid leukemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 58,875
Total Sell Value $0 $0 $0 $628,685
Total People Sold 0 0 0 3
Total Sell Transactions 0 0 0 3
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 32
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Obyrne Jason Chief Financial Officer   •       –      –    2024-02-20 4 A $0.00 $0 D/D 33,000 59,224     -
   Khan Ruhi Ahmad Chief Business Officer   •       –      –    2024-02-20 4 A $0.00 $0 D/D 33,000 33,000     -
   Mcclung Barbara G Chief Legal Officer   •       –      –    2024-02-20 4 A $0.00 $0 D/D 33,000 409,566     -
   Kanner Steven Chief Scientific Officer   •       –      –    2024-02-20 4 A $0.00 $0 D/D 33,000 387,037     -
   Haurwitz Rachel E. President and CEO   •       •      –    2024-02-20 4 A $0.00 $0 D/D 118,700 158,700     -
   Kanner Steven Chief Scientific Officer   •       –      –    2024-02-06 4 OE $2.69 $82,252 D/D 30,577 354,037     -
   Haurwitz Rachel E. President and CEO   •       •      –    2023-06-08 4 OE $2.96 $29,600 D/D 10,000 40,000     -
   Haurwitz Rachel E. President and CEO   •       •      –    2023-03-20 4 OE $2.96 $29,600 D/D 10,000 30,000     -
   Rizvi Syed Ali-Aamir Chief Medical Officer   •       –      –    2023-01-19 4 S $6.31 $35,506 D/D (5,627) 59,373 31%     
   Kanner Steven Chief Scientific Officer   •       –      –    2022-12-02 4 OE $2.69 $57,569 D/D 21,401 323,460     -
   Fischesser Ryan VP of Finance and Controller   •       –      –    2022-10-06 4 OE $2.69 $19,305 D/D 5,678 116,044     -
   Fischesser Ryan VP of Finance and Controller   •       –      –    2022-10-06 4 S $10.80 $107,958 D/D (10,000) 110,366 37%     
   Mcclung Barbara G Chief Legal Officer   •       –      –    2022-09-15 4 OE $2.69 $74,231 D/D 27,595 376,566     -
   Kanner Steven Chief Scientific Officer   •       –      –    2022-08-25 4 AS $11.22 $485,221 D/D (43,248) 302,059 -39%     
   Kanner Steven Chief Scientific Officer   •       –      –    2022-08-25 4 OE $2.69 $116,337 D/D 43,248 345,307     -
   Fischesser Ryan VP of Finance and Controller   •       –      –    2022-08-22 4 A $0.00 $0 D/D 4,848 120,366     -
   Kanner Steven Chief Scientific Officer   •       –      –    2022-05-13 4 OE $1.81 $140,081 D/D 74,420 302,059     -
   Haurwitz Rachel E. President and CEO   •       •      –    2022-05-09 4 OE $2.96 $29,600 D/D 10,000 20,000     -
   Fischesser Ryan VP of Finance and Controller   •       –      –    2022-03-15 4 OE $2.69 $7,733 D/D 2,274 113,244     -
   Kanner Steven Chief Scientific Officer   •       –      –    2022-03-04 4 OE $2.69 $31,036 D/D 10,720 227,639     -
   Obyrne Jason Chief Financial Officer   •       –      –    2022-02-08 4 OE $4.11 $100,021 D/D 24,336 24,336     -
   Haurwitz Rachel E. President and CEO   •       •      –    2022-01-26 4/A OE $2.96 $29,600 D/D 10,000 10,000     -
   Haurwitz Rachel E. President and CEO   •       •      –    2022-01-26 4 OE $2.96 $29,600 D/D 10,000 3,359,395     -
   Rizvi Syed Ali-Aamir Chief Medical Officer   •       –      –    2022-01-25 4 A $0.00 $0 D/D 60,000 65,000     -
   Rizvi Syed Ali-Aamir Chief Medical OfficerOfficer   •       –      –    2022-01-18 3 IO $0.00 $0 D/D 0 5,000 -24%     
  32 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us